Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles L Daley

Showing results (121-130 of 230) with videos related to

Pageof 23
Sort By:
Scientific Reports|February 22, 2020
miRNA Expression Profiles and Potential as Biomarkers in Nontuberculous Mycobacterial Pulmonary DiseaseSun Ae Han, Byung Woo Jhun, Su-Young Kim, et al.
Antimicrobial Agents and Chemotherapy|August 3, 2016
Peak Plasma Concentration of Azithromycin and Treatment Responses in Mycobacterium avium Complex Lung DiseaseByeong-Ho Jeong, Kyeongman Jeon, Hye Yun Park, et al.
Chest|July 9, 2018
US Patient-Centered Research Priorities and Roadmap for BronchiectasisEmily Henkle, Timothy R Aksamit, Charles L Daley, et al.
Chest|February 12, 2008
Detailed analysis of the radiographic presentation of Mycobacterium kansasii lung disease in patients with HIV infectionAdithya Cattamanchi, Payam Nahid, Theodore K Marras, et al.
ERJ Open Research|July 23, 2024
Brensocatib in non-cystic fibrosis bronchiectasis: ASPEN protocol and baseline characteristicsJames D Chalmers, Pierre-Régis Burgel, Charles L Daley, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2015
Response to Switch from Intermittent Therapy to Daily Therapy for Refractory Nodular Bronchiectatic Mycobacterium avium Complex Lung DiseaseWon-Jung Koh, Byeong-Ho Jeong, Kyeongman Jeon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 11, 2021
"One-Two Punch": Synergistic ß-Lactam Combinations for Mycobacterium abscessus and Target Redundancy in the Inhibition of Peptidoglycan Synthesis EnzymesDavid C Nguyen, Khalid M Dousa, Sebastian G Kurz, et al.
American Journal of Respiratory and Critical Care Medicine|June 30, 2012
The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatmentJakko van Ingen, Eric F Egelund, Adrah Levin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 2007
Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-gamma release assays in persons with suspected tuberculosisGerald H Mazurek, Stephen E Weis, Patrick K Moonan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 30, 2025
The Role of β-Lactam Antibiotics in Treating Mycobacterium abscessus: From Laboratory Insights to Clinical Applications and the Case for Clinical TrialsKhalid M Dousa, Eunjeong Shin, Sebastian G Kurz, et al.
Pageof 23

Showing results (121-130 of 230) with videos related to

Sort By:
Pageof 23
Scientific Reports|February 22, 2020
miRNA Expression Profiles and Potential as Biomarkers in Nontuberculous Mycobacterial Pulmonary DiseaseSun Ae Han, Byung Woo Jhun, Su-Young Kim, et al.
Antimicrobial Agents and Chemotherapy|August 3, 2016
Peak Plasma Concentration of Azithromycin and Treatment Responses in Mycobacterium avium Complex Lung DiseaseByeong-Ho Jeong, Kyeongman Jeon, Hye Yun Park, et al.
Chest|July 9, 2018
US Patient-Centered Research Priorities and Roadmap for BronchiectasisEmily Henkle, Timothy R Aksamit, Charles L Daley, et al.
Chest|February 12, 2008
Detailed analysis of the radiographic presentation of Mycobacterium kansasii lung disease in patients with HIV infectionAdithya Cattamanchi, Payam Nahid, Theodore K Marras, et al.
ERJ Open Research|July 23, 2024
Brensocatib in non-cystic fibrosis bronchiectasis: ASPEN protocol and baseline characteristicsJames D Chalmers, Pierre-Régis Burgel, Charles L Daley, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2015
Response to Switch from Intermittent Therapy to Daily Therapy for Refractory Nodular Bronchiectatic Mycobacterium avium Complex Lung DiseaseWon-Jung Koh, Byeong-Ho Jeong, Kyeongman Jeon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 11, 2021
"One-Two Punch": Synergistic ß-Lactam Combinations for Mycobacterium abscessus and Target Redundancy in the Inhibition of Peptidoglycan Synthesis EnzymesDavid C Nguyen, Khalid M Dousa, Sebastian G Kurz, et al.
American Journal of Respiratory and Critical Care Medicine|June 30, 2012
The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatmentJakko van Ingen, Eric F Egelund, Adrah Levin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 2007
Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-gamma release assays in persons with suspected tuberculosisGerald H Mazurek, Stephen E Weis, Patrick K Moonan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 30, 2025
The Role of β-Lactam Antibiotics in Treating Mycobacterium abscessus: From Laboratory Insights to Clinical Applications and the Case for Clinical TrialsKhalid M Dousa, Eunjeong Shin, Sebastian G Kurz, et al.
Pageof 23